Aptamer Sciences, Inc.
1 clinical trials · Sponsor
◉ Watch Aptamer Sciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors (NCT06687941) | Aptamer Sciences, Inc. | 2025-03-11 |
Track Aptamer Sciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.